Rostec has Delivered more than 100,000,000 Vaccine Doses to Prevent Harmful Diseases

Rostec has Delivered more than 100,000,000 Vaccine Doses to Prevent Harmful Diseases

Nacimbio holding, Rostec State Corporation, has supplied the total amount of vaccines planned by the company for 2022 to the regions of Russia according to the National Immunization Schedule (NIS). In the current year, all deliveries were completed ahead of schedule almost by a month. 

Against the order of the Ministry of Health of Russia, 107,000,000 measles, rubella, parotitis, tuberculosis, tetanus, diphtheria, pertussis, hepatitis B and influenza vaccine doses were delivered to the medical facilities in 85 regions of the country.

Influenza vaccines constituted the major part of the supply chain – more than 69,000,000 doses. The share of Rostec’s pharmaceutical holding in the centralized state order for vaccines according to NIS 2022 was about 90% by volume. 

“Nacimbio has successfully fulfilled the scope of supply of vaccines for 2022 according to the National Immunization Schedule in full and ahead of schedule by 20 days. The holding has a wide vaccine transportation experience, required production facilities and clearly established logistic chains that allowed to fulfil the order of the Ministry of Health of Russia in advance,” said Oleg Evtushenko, Rostec’s Executive Director. 

“Since 2015, Nacimbio has been a key supplier of immunobiologicals fully made in Russia for NIS. From 2015 to 2022, the company delivered more than 1 bln. vaccine doses to public medical facilities. The holding’s production capacities allow to make about 110,000,000 various vaccine doses annually.